Order Article Reprints

Larionov A, Fewings E, Redman J, Goldgraben M, Clark G, Boice J, Concannon P, Bernstein J, Conti DV, the WECARE Study Collaborative Group, et al. The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women. Cancers. 2023; 15(2):415. https://doi.org/10.3390/cancers15020415

Larionov, Alexey, Eleanor Fewings, James Redman, Mae Goldgraben, Graeme Clark, John Boice, Patrick Concannon, Jonine Bernstein, David V. Conti, the WECARE Study Collaborative Group, and et al. 2023. "The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women" Cancers 15, no. 2: 415. https://doi.org/10.3390/cancers15020415

Larionov, A., Fewings, E., Redman, J., Goldgraben, M., Clark, G., Boice, J., Concannon, P., Bernstein, J., Conti, D. V., the WECARE Study Collaborative Group, & Tischkowitz, M. (2023). The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women. Cancers, 15(2), 415. https://doi.org/10.3390/cancers15020415